Prof. Hakan Özveri is a urology specialist with a medical degree from Marmara University Faculty of Medicine (1997). He has been a part of Acıbadem Health Group since 2004, bringing years of clinical experience in urology, with particular engagement in minimally invasive and endourological procedures. He is an active member of several professional organizations, including the Endourology Association, Turkish Andrology Association, European Urological Association, Turkish Urology Association, and the Turkish Uro-Oncology Society. These memberships reflect his commitment to staying current with advances in urology and contributing to professional collaboration and education. Known for a patient-centered approach, he combines surgical expertise with a focus on men’s health and oncological care, aiming to deliver evidence-based treatment and compassionate support throughout diagnosis and recovery.
Education
- 1997 Marmara University Faculty of Medicine Urology
- 1991 Istanbul University Cerrahpasa Faculty of Medicine
Experience
- 2004 Acibadem Health Group
- 1997 – 2004 Uro-Medical Urology Diagnostic Center
- 1997 – 2004 Uro-Medical Urology Diagnostic Center
- 1997 Boston Medical Center Andrology Department, U.S.A./ Fellowship
- 1997 Sackler School of Medicine Assaf Harofeh Medical Center, Israel / Endourology, Urooncology Fellowship
- 1992 – 1997 Marmara University Faculty of Medicine, Department of Urology, Residency
Memberships
- Endourology Association
- Turkish Andrology Association
- European Urological Association
- Turkish Urology Association
- Turkish Uro-Oncology Society
Publications
- Lack of effect of intrarectal lidocaine for pain control during transrectal biopsy: A randomized prospective study.
Eur Urol, 29:189-192, 2002 Çevik İ., Özveri H., Dillioğlugil Ö., Akdaş A. - The role of bisphosphonates in the treatment of prostate cancer.
Actual Medicine, 11: 4, 14-16, 2003 A. Akdaş, H. Özveri, İ. Çevik. - Transrectal periprostatic lidocaine injection anesthesia for transrectal prostate biopsy: a prospective study.
Prostate Cancer and Prostatic Diseases, 6:311-314, 2003 Özveri H. , Çevik İ., Dillioğlugil Ö., Akdaş A. - Lack of effect of intrarectal lidocaine for pain control during transrectal biopsy: A randomized prospective study.
Eur Urol, 29:189-192, 2002 Çevik İ., Özveri H., Dillioğlugil Ö., Akdaş A. - The place of neadjuvant chemotherapy in invasive bladder cancer.
Int J. Urol. Nephrol, 33(1): 49-52. 2002 Çam K., Yıldırım A., Özveri H., Türkeri L., Akdaş A. - The role of prostate specific antigen, Gleason score, digital rectal examination, and transrectal ultrasonography in the prediction of extracapsular prostate cancer.
Ozveri H, Cam K, Turkeri L, Tarcan T, Akdas A. J of BUON, 6 (1):87-90 (2001) - Early diagnosis of prostate cancer among 1181 patients attending an urology outpatient department.
J of BUON, 5:389-392 (2000) Özveri H, Çam K, Tarcan T, Türkeri L, Akdaş A. - Alteration of Epidermal Growth Factor Receptor Expression Following Ischaemia of Renal Tissue.
Int. J. Urol and Nephrol 31 (5), pp 611-617, 1999 Ertugrul A., Türkeri L.N., Özyürek M., Özveri H., Akdaş A. - The role of Hypoechoic lesion directed biopsies and free to total PSA ratio in diagnosis of prostate cancer patients with normal DRE and total PSA levels between 4-20 ng/ml. Proceedings of 4th Seminar of the International Cooperative Study of Diagnostic Ultrasound and Prostate Cancer.
Tokyo, Japan. P:123-126, 1998 Özveri H , Çam K, Özveren B, Türkeri L, Akdaş A.
